HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 299 filers reported holding HAEMONETICS CORP in Q4 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $6,288 | +36.4% | 76 | +40.7% | 0.00% | 0.0% |
Q1 2024 | $4,609 | +1243.7% | 54 | +1250.0% | 0.00% | – |
Q4 2023 | $343 | -94.8% | 4 | -94.5% | 0.00% | -100.0% |
Q3 2023 | $6,539 | -56.6% | 73 | -58.8% | 0.00% | -50.0% |
Q2 2023 | $15,070 | +48.1% | 177 | +43.9% | 0.00% | +33.3% |
Q1 2023 | $10,178 | -15.4% | 123 | -19.6% | 0.00% | 0.0% |
Q4 2022 | $12,033 | +20.3% | 153 | +11.7% | 0.00% | 0.0% |
Q3 2022 | $10,000 | – | 137 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bridge City Capital, LLC | 40,541 | $5,114,000 | 2.20% |
Lisanti Capital Growth, LLC | 53,385 | $6,734,000 | 2.20% |
Nitorum Capital, L.P. | 279,510 | $35,257,000 | 2.05% |
CROWN ADVISORS MANAGEMENT, INC. | 20,000 | $2,523,000 | 1.69% |
Millrace Asset Group, Inc. | 11,400 | $1,438,000 | 1.69% |
COOKSON PEIRCE & CO INC | 145,884 | $18,402,000 | 1.61% |
Endurant Capital Management LP | 32,594 | $4,111,000 | 1.48% |
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 111,000 | $14,002,000 | 1.38% |
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 110,065 | $13,884,000 | 1.37% |
EMERALD ADVISERS, LLC | 203,640 | $25,687,000 | 1.20% |